US 10526295
Nuclear transport modulators and uses thereof
granted A61PA61P17/02A61P35/00
Quick answer
US patent 10526295 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P17/02, A61P35/00, A61P7/00